secwatch.observer — SEC 8-K summary
======================================

Issuer:     Charlotte's Web Holdings, Inc. (CWBHF)
CIK:        0001750155
Form:       8-K
Filed at:   2026-06-05T21:20:54+00:00
Accession:  0001750155-26-000097
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Charlotte's Web co-founder Jared Stanley resigns from board to focus on DeFloria Phase 2 drug
--------------------------------------------------------------------------------

- Co-founder Jared Stanley resigned from Board on June 3, 2026 to become CEO of DeFloria, advancing its FDA Phase 2 botanical drug for autism irritability.
- Charlotte's Web co-founded DeFloria in 2023 with AJNA BioSciences; DeFloria is developing AJA001 oral solution for autism irritability.
- Stanley will remain as advisor to Charlotte's Web and continue as ONE HEMP representative.
- Board size reduced to six directors following Stanley's resignation.
- Departure not due to any disagreement with management or operations per company statement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1750155/000175015526000097/0001750155-26-000097-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1750155/000175015526000097/cweb-20260603.htm
  HTML page:      https://secwatch.observer/filing/0001750155-26-000097

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer